| Project/Area Number |
22591643
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Orthopaedic surgery
|
|---|
| Research Institution | Tokai University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
TAMAKI Tetsuro 東海大学, 医学部, 准教授 (10217177)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 骨格筋幹細胞 / 末梢神経 / 再生 / 生体吸収性チューブ / 末梢神経再生 / 幹細胞移植 / 骨格筋間質幹細胞 / 生体チューブ / 骨格筋間質幹由来細胞 / 細胞移植 / 生体吸収チューブ / シュワン細胞 / 神経周膜細胞 / 人工神経 |
|---|
| Research Abstract |
To develop the new therapy for the irreversible long nerve deficit, we applied skeletal muscle-derived multipotent stem cell sheet pellets (Sk-MSCSPs), as a novel alternative source of nerve autograft. We used the tubeto the dcellularized conduit (dehydrated esophageal submucous membrane by 70% ethanol). After 4 weeks, conduit was filed by GFP+ cells/tissues, and engrafted GFP+ donor cells/tissues obviously stretch back to proximal portion of recipient nerve. After 8 weeks, theabove properties were more enhanced. These results strongly suggested that Sk-MSCSPs may be the best suitable stem cells for the long nerve gap therapy. Therefore, we want to continue further study with the aim of clinical application.
|
